Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Atovaquone × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2 Other hematologic neoplasm 1 Gynecologic 1 CNS 1

Conditions

Medulloblastoma 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Temozolomide 531 Radiotherapy 339 Bevacizumab 222 Magnetic Resonance Spectroscopy 180 Cyclophosphamide 151 Carboplatin 136 Radiosurgery 133 Etoposide 110 Radiation 105 Irinotecan 102 Vincristine 94 Cisplatin 84 Filgrastim 81 Specimen Handling 76 pembrolizumab 75 Lomustine 73 Nivolumab 72 Topotecan 59 Surgical Procedures, Operative 59 Melphalan 51 Carmustine 50 sargramostim 46 Radiotherapy, Intensity-Modulated 45 Isotretinoin 45 Doxorubicin 45 Peripheral Blood Stem Cell Transplantation 44 Granulocyte Colony-Stimulating Factor 44 Erlotinib Hydrochloride 41 Chemotherapy, Adjuvant 41 Granulocyte-Macrophage Colony-Stimulating Factor 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06624371 2025-07-22

AflacBT2303

Emory University

Phase 1 Recruiting

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡